News | June 14, 2026
India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Health Ministry reviews progress, highlights targeted interventions in high-burden states, and calls for stronger surveillance and stigma reduction to achieve a leprosy-free India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
